J Infect Dis

September 14, 2015 by
Peace Mirembe (V3locity)

Gianella S, Redd AD, Grabowski MK, Tobian AA, Serwadda D, Newell K, Patel EU, Kalibbala S, Ssebbowa P, Gray RH, Quinn TC, Reynolds SJ. Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda.

2015 Mar 5. pii: jiv135. [Epub ahead of print]. PMID: 2574342


Abstract

Vaginal shedding of cytomegalovirus (CMV) DNA was determined longitudinally among 96 women coinfected with human immunodeficiency virus (HIV), herpes simplex virus 2, and CMV starting antiretroviral therapy (ART) during a placebo-controlled trial of HSV-2 suppression with acyclovir in Rakai, Uganda. Vaginal CMV was detected in 75 of 96 women (78.0%) and 379 of 1080 individual visits (35.1%). ART status, higher HIV RNA viral load before ART initiation, and younger age were significantly associated with increased frequency of CMV shedding (P < .01). Compared to pre-ART, CMV shedding peaked from month 2 to month 4 after ART initiation, suggesting possible immune reconstitution inflammatory syndrome. Further studies need to determine the clinical significance of asymptomatic CMV shedding.

Read More



Share this post
Tags
Archive